bemarituzumab
Generic: FPA144·Code: FPA144
bemarituzumab: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| FIVE PRIME THERAPEUTICS, INC. (FPRX) | Phase 3 |
Get deeper analysis on bemarituzumab
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis